Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells.
about
Immunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulationAnalysis of the toxicity of gold nano particles on the immune system: effect on dendritic cell functionsNano polymeric carrier fabrication technologies for advanced antitumor therapyTrafficking of a dual-modality magnetic resonance and fluorescence imaging superparamagnetic iron oxide-based nanoprobe to lymph nodes.Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo[Gd@C(82)(OH)(22)](n) nanoparticles induce dendritic cell maturation and activate Th1 immune responses.Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.Application of nanotechnologies for improved immune response against infectious diseases in the developing worldDrug transport to brain with targeted nanoparticles.Polyelectrolyte capsules-containing HIV-1 p24 and poly I:C modulate dendritic cells to stimulate HIV-1-specific immune responses.Delivery of a peptide via poly(D,L-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell-stimulatory capacity.The nanomaterial-dependent modulation of dendritic cells and its potential influence on therapeutic immunosuppression in lupus.Synthesis and characterization of PLGA nanoparticles.Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the AntigenDevelopment and validation of TLC-densitometric method for determination of lipid A adjuvant as a bulk and in solid fat nanoemulsions.Nanoliposomes of L-lysine-conjugated poly(aspartic acid) Increase the Generation and Function of Bone Marrow-derived Dendritic CellsTargeting dendritic cells with antigen-containing liposomes: antitumour immunity.PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.Ex Vivo and In Vitro Studies on the Cytotoxicity and Immunomodulative Properties of Poly(2-isopropenyl-2-oxazoline) as a New Type of Biomedical Polymer.Identification of BALB/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine.Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growthMultivalent porous silicon nanoparticles enhance the immune activation potency of agonistic CD40 antibody.Biodegradable particles as vaccine delivery systems: size mattersThe effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cellsMaterials that harness and modulate the immune system.Vaccine delivery using nanoparticles.Induction of Potent Antigen-specific Cytotoxic T Cell Response by PLGA-nanoparticles Containing Antigen and TLR AgonistConfiguration-dependent Presentation of Multivalent IL-15:IL-15Rα Enhances the Antigen-specific T Cell Response and Anti-tumor ImmunityPLGA-polymer encapsulating tumor antigen and CpG DNA administered into the tumor microenvironment elicits a systemic antigen-specific IFN-γ response and enhances survival.Design of nanoparticle-based dry powder pulmonary vaccines.Polyanhydride microparticles enhance dendritic cell antigen presentation and activation.Strategies used for MUC1 immunotherapy: preclinical studies.Nanoparticle-detained toxins for safe and effective vaccination.Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses.Cancer immunotherapy and nanomedicine.Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses.Multifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes.Peptide/protein vaccine delivery system based on PLGA particles.Immunotherapeutic restoration in HIV-infected individuals.The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant.
P2860
Q26825654-C647AB98-3F25-4C82-8D20-A177778446FEQ28391097-B389CE52-7EFA-4B2E-BF91-BAD5F8B21F8FQ28393168-212671DC-D963-4E69-AE09-4984F9D100ECQ30501226-67B8FF75-0078-4CF8-9994-D42A2EA73740Q33517131-2B714D05-2B96-4EF0-B570-946305744B8CQ33715235-7E8CE16B-FABD-4B3D-9B88-C6C2289BB14DQ33819656-EBB33466-5B60-4CEB-8EC9-A60B90374CDDQ33894321-E31E83EF-88FB-48D2-9323-0E4B10AADF33Q33985140-C57FD004-7212-4F36-A4A6-7335B7753F65Q34025136-E02AF326-8A8F-423E-A653-8471598F76C3Q34164104-54434427-6765-4681-8CA8-598D9D8AC75DQ34180779-E5AA292F-3859-4246-8509-30603FB5D949Q34524402-06DF717C-CC17-4502-A24E-4C0D2849A5EEQ35157029-B58320E2-1106-4C78-B184-9DF7A066C41CQ35566418-1A637661-DCBB-4047-86AF-63B8E5C46183Q35624557-984CDD16-E289-4A4E-A2FB-4378578F999BQ35925604-36CE9FB0-9C91-4CE0-98FC-2454AB8E640DQ35972569-8AEA4458-3AEC-40D2-9DF7-1D32D3518D3DQ36010045-28453FD6-5D28-4786-9A60-0882461B9CE7Q36257481-D42BD7C8-6663-4838-A4FD-B28DEBEA6F9BQ36322686-836CEF9B-3119-4DAB-AF76-1B0847465D9BQ36452648-AB9424F2-79AA-49F5-B9B3-B826ACCB93A1Q36502434-77173F76-9508-4671-B8A9-FE70E2CE697DQ36553255-94A49A5D-FA53-42B1-BB06-C35028F00FD2Q36690859-50FFD9A1-D3D3-4C8C-8BCD-275BC075A6B0Q36712817-C3339453-EFBA-472F-BE40-77A886C6B43BQ36714925-5E589FD3-0D20-4B78-92C4-5E417C287DD7Q36884768-5C73FD09-BCD5-47AB-A6F7-874BEE6AE12BQ36897208-928A5BCC-3D77-4075-830B-0978711DF1CAQ36985908-26C97502-D76E-4E57-9FF8-867824615106Q37010485-5B76482F-B1C8-4F40-B2ED-636925807C62Q37259594-5373A69A-3030-4E24-A0C6-3F67BA5E879BQ37426321-D8C6FA03-0DC1-43AB-A3A8-401ABB8535A8Q37607079-2A1C4857-E29C-450A-9ED3-E5252249608DQ37785836-2B9FB110-280F-4C84-AC33-4F8789CDA0A2Q37785952-DA4433A5-C187-49E1-9DC3-6DF62F4E199BQ37820820-C2824A8C-E1CF-40EE-9AC7-EE1A2D480F11Q37838652-B622E4B2-6656-42B4-AB8D-A9F598226DD3Q37842335-B9752FBE-E4CA-4F06-99B8-13C7291568D1Q37956385-2830FAC4-7D4A-475F-8FF1-C079AC8AF319
P2860
Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Characterization of poly(D,L-l ...... f antigens to dendritic cells.
@en
Characterization of poly(D,L-l ...... f antigens to dendritic cells.
@nl
type
label
Characterization of poly(D,L-l ...... f antigens to dendritic cells.
@en
Characterization of poly(D,L-l ...... f antigens to dendritic cells.
@nl
prefLabel
Characterization of poly(D,L-l ...... f antigens to dendritic cells.
@en
Characterization of poly(D,L-l ...... f antigens to dendritic cells.
@nl
P2093
P1433
P1476
Characterization of poly(D,L-l ...... f antigens to dendritic cells.
@en
P2093
John Samuel
Manish Diwan
Praveen Elamanchili
P304
P356
10.1016/J.VACCINE.2003.12.032
P407
P577
2004-06-01T00:00:00Z